USFDA conducts GMP inspection at Indoco Remedies’ Solid Oral Formulation Facility in Goa

23 Jan 2023 Evaluate

The United States Food and Drug Administration (USFDA) have conducted GMP inspection at Indoco Remedies’ Solid Oral Formulation Facility (Plant 1) in Goa. The inspection was conducted from January 16, 2023 to January 20, 2023.

The USFDA has issued Form 483 with 9 observations, which will be addressed within stipulated time. The company is committed to maintain compliances across all our facilities with cGMP quality standards at all times.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

321.05 1.35 (0.42%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.